Metabolic syndrome in women with and without interstitial cystitis/bladder pain syndrome
Metabolic syndrome in women with and without interstitial cystitis/bladder pain syndrome
复制标题
患有或不患有间质性膀胱炎/膀胱疼痛综合征的女性的代谢综合征
DOI:
10.1007/s00192-020-04605-w
复制
发表时间:
2020-11
影响因子:
1.8
通讯作者:
De-yi Luo
中科院分区:
文献类型:
--
作者:
Liao Peng;Xing-peng Di;Shi-xin He;Xiao Zeng;Hong Shen;Hui-Li Zhu;De-yi Luo
Introduction and hypothesisThe aim of this study was to compare the frequency of metabolic syndrome (MetS) in patients with and without interstitial cystitis/bladder pain syndrome (IC/BPS).MethodsThis case-control study evaluated the indicators of MetS in 287 females with IC/BPS and in 287 females without IC/BPS in West China Hospital between January 2010 and January 2020. Then, the number of voids per day, frequency of night urination, O’Leary-Sant Interstitial Cystitis Symptom/Problem Index, and visual analog scale were examined in the two groups.ResultsBased on both the National Cholesterol Education Program Adult Treatment Panel III recommendations and the International Diabetes Federation criteria, the distribution of MetS was statistically higher in patients with IC/BPS than in the control group, with 34.8% vs 17.8% (P< 0.0001) and 34.2% vs 20.9% (P= 0.0005), respectively. Regarding symptom scores, the IC/BPS group demonstrated significantly higher scores than the control group in all aspects (P< 0.0001). More patients with anxiety (P< 0.0001), insomnia (P< 0.0001), hypertension (P= 0.0001), and diabetes mellitus (P= 0.017) were observed in the IC/BPS group. Moreover, the findings indicated that patients with IC/BPS had a higher BMI (P= 0.0001) and larger waist circumference (P= 0.0001). Blood tests presented a significantly higher level of fasting glycemia, serum cystatin-C, and triglycerides in patients with IC/BPS. Furthermore, higher ORs for the occurrence of MetS among cases were observed, although this was not statistically significant.ConclusionsMetS frequency was relatively high in patients with IC/BPS. Further research is needed to understand the common pathophysiologic mechanism of IC/BPS and MetS.
登录
查看更多内容
影响因子:
9.8
作者:
Y. Kim;J. Kim;Sun Mie Kim;Yunhee Choi;M. Jeon
通讯作者:
Y. Kim;J. Kim;Sun Mie Kim;Yunhee Choi;M. Jeon
影响因子:
23.4
作者:
Temml, Christian;Wehrberger, Clemens;Madersbacher, Stephan
通讯作者:
Madersbacher, Stephan
影响因子:
2.3
作者:
Jhang JF;Kuo HC
通讯作者:
Kuo HC
影响因子:
37.8
作者:
Alberti, K. G. M. M.;Eckel, Robert H.;Smith, Sidney C., Jr.
通讯作者:
Smith, Sidney C., Jr.
DOI:
10.2147/dmso.s106221
发表时间:
2016
期刊:
Diabetes, metabolic syndrome and obesity : targets and therapy
影响因子:
--
作者:
de Oliveira MC;Varella LR;Angelo PH;Micussi MT
通讯作者:
Micussi MT